SE8200639L - Forfarande for framstellning av anti-t-lymfocytglobulin - Google Patents

Forfarande for framstellning av anti-t-lymfocytglobulin

Info

Publication number
SE8200639L
SE8200639L SE8200639A SE8200639A SE8200639L SE 8200639 L SE8200639 L SE 8200639L SE 8200639 A SE8200639 A SE 8200639A SE 8200639 A SE8200639 A SE 8200639A SE 8200639 L SE8200639 L SE 8200639L
Authority
SE
Sweden
Prior art keywords
lymphocyte globulin
procedure
cells
preparing anti
lymphocytes
Prior art date
Application number
SE8200639A
Other languages
English (en)
Other versions
SE460826B (sv
Inventor
H Thimel-Baumer
Original Assignee
Fresenius Chem Pharm Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Chem Pharm Ind filed Critical Fresenius Chem Pharm Ind
Publication of SE8200639L publication Critical patent/SE8200639L/sv
Publication of SE460826B publication Critical patent/SE460826B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8200639A 1981-02-12 1982-02-04 Foerfarande foer framstaellning av anti-t-lymfocytglobulin SE460826B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813105150 DE3105150A1 (de) 1981-02-12 1981-02-12 Herstellung von anti-t-lymphozyten-globulin.

Publications (2)

Publication Number Publication Date
SE8200639L true SE8200639L (sv) 1982-08-13
SE460826B SE460826B (sv) 1989-11-27

Family

ID=6124731

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8200639A SE460826B (sv) 1981-02-12 1982-02-04 Foerfarande foer framstaellning av anti-t-lymfocytglobulin

Country Status (19)

Country Link
US (1) US4541953A (sv)
AT (1) AT377698B (sv)
AU (1) AU550257B2 (sv)
BE (1) BE891944A (sv)
CA (1) CA1184491A (sv)
CH (1) CH652410A5 (sv)
DE (1) DE3105150A1 (sv)
DK (1) DK56882A (sv)
ES (1) ES8401982A1 (sv)
FI (1) FI72139C (sv)
FR (1) FR2499413B1 (sv)
GB (1) GB2093037B (sv)
HU (1) HU189998B (sv)
IT (1) IT1195296B (sv)
LU (1) LU83932A1 (sv)
NL (1) NL8200458A (sv)
NO (1) NO157422C (sv)
SE (1) SE460826B (sv)
ZA (1) ZA82905B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3483996D1 (de) * 1983-09-15 1991-02-28 Univ Leland Stanford Junior Allotransplantat mit verminderter immunogenitaet und verfahren und reagenz fuer seine herstellung.
US4681760A (en) * 1985-04-17 1987-07-21 The Board Of Trustees Of The Leland Stanford Junior University Method of conferring immunotolerance to a specific antigen
US5011684A (en) * 1985-09-05 1991-04-30 Beth Israel Hospital Association Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
US5785966A (en) * 1994-06-15 1998-07-28 Coles; John G. Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
FR2878852B1 (fr) * 2000-09-28 2007-02-23 Imtix Sangstat Procede de production d'immunoglobulines anti-thymocytes humains

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363799A (en) * 1979-03-20 1982-12-14 Ortho Pharmaceutical Corporation Monoclonal antibody to human T cells, and methods for preparing same
US4361549A (en) * 1979-04-26 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
US4361550A (en) * 1979-12-04 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human suppressor T cells and methods of preparing same
US4364933A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human thymocyte antigen and methods of preparing same
US4364935A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human prothymocyte antigen and methods of preparing same

Also Published As

Publication number Publication date
FI72139B (fi) 1986-12-31
NO157422C (no) 1988-03-16
IT1195296B (it) 1988-10-12
ATA11482A (de) 1984-09-15
NL8200458A (nl) 1982-09-01
ES509504A0 (es) 1984-01-16
FR2499413B1 (fr) 1985-08-30
CH652410A5 (de) 1985-11-15
AU550257B2 (en) 1986-03-13
AU8037382A (en) 1982-08-19
FI72139C (sv) 1987-04-13
SE460826B (sv) 1989-11-27
US4541953A (en) 1985-09-17
HU189998B (en) 1986-08-28
LU83932A1 (de) 1982-07-07
FI820233L (fi) 1982-08-13
AT377698B (de) 1985-04-25
CA1184491A (en) 1985-03-26
ZA82905B (en) 1982-12-29
NO157422B (no) 1987-12-07
GB2093037A (en) 1982-08-25
GB2093037B (en) 1984-07-18
NO820014L (no) 1982-08-13
IT8125247A0 (it) 1981-11-24
DE3105150C2 (sv) 1989-02-23
BE891944A (fr) 1982-05-17
DK56882A (da) 1982-08-13
ES8401982A1 (es) 1984-01-16
FR2499413A1 (fr) 1982-08-13
DE3105150A1 (de) 1982-08-19

Similar Documents

Publication Publication Date Title
DE3751908D1 (de) Chimärisches Murine-Mensch-Immunoglobulin, spezifisch für tumorassoziertes 17-1A Antigen
DK154769C (da) Monoklonalt antistof, fremstilling heraf, hybridomacellelinie til anvendelse ved fremstilling heraf samt fremgangsmaader til anvendelse heraf
ES497425A0 (es) Un metodo de preparacion de un anticuerpo monoclonal.
JPS6447378A (en) Monoclonal antibody to black tumor related antigen, hybrid cell line for producing the same and use thereof
AU544792B2 (en) Monoclonal antibodies to human helper t cells
GB2128631A (en) Antibodies having dual specificities their preparation and uses therefor
ATE13198T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches t-zellenantigen, antikoerper und verfahren.
IE800565L (en) Monoclonal antibodies to human t cells
ES497422A0 (es) Un metodo de preparacion de un inticuerpo monocloral.
DK154093C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt diagnostisk praeparat med det fremstillede monoklonale antistof
AU545181B2 (en) Hybridoma for producing monoclonal antibodies
DK190287A (da) Monoklonale antistoffer til human-interleukin-2-receptor samt hybridcellelinier til fremstilling deraf
DE3650032D1 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
DK154090C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistof
SE8200639L (sv) Forfarande for framstellning av anti-t-lymfocytglobulin
EP0104014A3 (en) Cell surface antigens of human astrocytoma
KR890007755A (ko) 베타-배열의 n-아세틸뉴라민산을 인지할 수 있는 단일 클론성 항체
EP0141616A3 (en) Hybrid cell lines producing monoclonal antibodies directed against trichomonas vaginalis determinants
JPS57208458A (en) Labeled antibody for immunochemical measurement
EP0155172A3 (en) Anti-human lung cancer monoclonal antibodies
Estess STRUCTURAL AND SEROLOGICAL ANALYSES OF MONOCLONAL A/J ANTI-ARSONATE ANTIBODIES WITH AND WITHOUT A CROSS-REACTIVE IDIOTYPE.
NO874799D0 (no) Fremgangsmaate for fremstilling av monoklonale antistoffer ved dyrking av hybridom-cellelinjen lym-2.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8200639-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8200639-6

Format of ref document f/p: F